Format

Send to:

Choose Destination
See comment in PubMed Commons below
Science. 2005 Oct 14;310(5746):239-40.

Intellectual property. Enhanced: intellectual property landscape of the human genome.

Author information

  • 1Department of Chemical Engineering, Sloan School of Management, Massachusetts Institute of Technology, Cambridge, MA 02139, USA.

Abstract

The impact of gene patents on downstream research and innovation are unknown, in part because of a lack of empirical data on the extent and nature of gene patenting. In this Policy Forum, the authors show that 20% of human gene DNA sequences are patented and that some genes are patented as many as 20 times. Unsurprisingly, genes associated with health and disease are more patented than the genome at large. The intellectual property rights for some genes can become highly fragmented between many owners, which suggests that downstream innovators may face considerable costs to gain access to gene-oriented technologies.

PMID:
16224006
[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for HighWire
    Loading ...
    Write to the Help Desk